Back
SCYNEXIS, Inc. Vs. BridgeBio Pharma, Inc. Industry Stock Comparison
Sell
47
SCYX
SCYNEXIS, Inc.
Last Price:
$0.90
Seasonality Move:
-4.6%
Buy
51
BBIO
BridgeBio Pharma, Inc.
Last Price:
$73.17
Seasonality Move:
5.25%
Sell
47
SCYNEXIS, Inc. (SCYX)
is a Sell
Is SCYNEXIS, Inc. a Buy, Sell or Hold?
-
The current SCYNEXIS, Inc. [SCYX] share price is $0.89. The Score for SCYX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
SCYX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
51
BridgeBio Pharma, Inc. (BBIO)
is a Buy
Is BridgeBio Pharma, Inc. a Buy, Sell or Hold?
-
The current BridgeBio Pharma, Inc. [BBIO] share price is $73.15. The Score for BBIO is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
-
BBIO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SCYX Stock Price Chart
What is SCYNEXIS, Inc.'s stock price today?
-
The SCYNEXIS, Inc. share price today is $0.89Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SCYX is experiencing buying pressure, which is a positive indicator for future bullish movement.
BBIO Stock Price Chart
What is BridgeBio Pharma, Inc.'s stock price today?
-
The BridgeBio Pharma, Inc. share price today is $73.15Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BBIO is experiencing slight selling pressure.
SCYX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.23 | Buy |
| Relative Strength Index (14 RSI): | 55.03 | Buy |
| Chaikin Money Flow: | 134964 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.79 - 0.91) | Buy |
| Bollinger Bands (100): | (0.62 - 0.82) | Buy |
BBIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.66 | Buy |
| Relative Strength Index (14 RSI): | 55.21 | Buy |
| Chaikin Money Flow: | -128497 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (66.58 - 72.4) | Buy |
| Bollinger Bands (100): | (67.73 - 76.59) | Buy |
SCYX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.86 | Buy |
| 20-day SMA: | 0.88 | Buy |
| 50-day SMA: | 0.81 | Buy |
| 200-day SMA: | 0.77 | Buy |
| 8-day EMA: | 0.83 | Buy |
| 20-day EMA: | 0.61 | Buy |
| 50-day EMA: | 0.33 | Buy |
| 200-day EMA: | 0.1 | Buy |
BBIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 71.71 | Buy |
| 20-day SMA: | 70.4 | Buy |
| 50-day SMA: | 71.53 | Buy |
| 200-day SMA: | 61.39 | Buy |
| 8-day EMA: | 72.08 | Buy |
| 20-day EMA: | 70.93 | Buy |
| 50-day EMA: | 70.94 | Buy |
| 200-day EMA: | 62.01 | Buy |
SCYNEXIS, Inc. Earnings Growth & SCYX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.18 per share, and an increase next year of $0.16 per share.
BridgeBio Pharma, Inc. Earnings Growth & BBIO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.27 per share, an increase next quarter of $0.26 per share, an increase this year of $1.05 per share, and an increase next year of $2.15 per share.
SCYNEXIS, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
BridgeBio Pharma, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||